Clinical Trial Update: Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating a two-drug regimen of lopinavir/ritonavir plus lamivudine in HIV patients with viral suppression; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Kaletra (lopinavir)

Snippet

Sponsor: Juan A. Arnaiz | Conditions: HIV Infection | Phase 4 | Status: COMPLETED